EPRT vs FSV

EPRT presents a dichotomy between strong operational performance and stretched deterministic valuations. While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is robust with low debt/equity (0.60), the stock trades at a significant premium to its Graham Number ($23.92) and Intrinsic Value ($8.89). Strong revenue growth (22.8%) is offset by a dangerously high dividend payout ratio (96.06%) and bearish insider activity from the CFO and CIO. Despite a 'Strong Buy' analyst consensus, the technical trend is currently bearish, suggesting a period of consolidation or correction.

FSV demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. However, the stock is trading at a significant premium, with a current price of $145.74 far exceeding both its Graham Number ($46.33) and Intrinsic Value ($93.52). While earnings growth is robust at 19.5% and analysts maintain a bullish target of $207, the technical trend is severely bearish (0/100) with a 20.5% decline over the last six months. The investment case currently rests on a conflict between high-quality internal health and an overextended valuation in a downward price trend.